Explore This

Overview

This year over 50,000 men and women in the U.S. will die from colon cancer. And many could have been saved. When colon cancer is detected early, there is a 90% survival rate. When it's not, that number is less than 50%. Starting at age 50, you should have a colonoscopy at least once every ten years to screen for polyps and cancer. Colon cancer can be beaten. Prevention and early detection are your best weapons.

We offer the most advanced colon cancer screenings and treatments available. Our world-renowned specialists can provide the comprehensive care and peace of mind you'll only find at one of the world's leading hospitals.

Talk to your doctor about scheduling your colorectal cancer screening at Massachusetts General Hospital. Then call (617) 726-2426 or request an appointment online.

Please visit our doctors page for a list of our gastroenterologists.

High-risk Cancer Genetics Program

Some individuals and families are at much higher risk of specific gastrointestinal cancers. The following factors can increase your risk of cancer:

  • Personal or family history of colon polyps or cancer
  • Familial Adenomatous Polyposis (Gardner's Syndrome)
  • MYH-Associated Polyposis (MAP)
  • Hereditary Nonpolyposis Colorectal Cancer (HNPCC) syndrome
  • Lynch Syndrome
  • Hamartomatous Polyposis syndromes such as Peutz-Jeghers or Juvenile Polyposis
  • Personal or family history of endometrial cancer or ovarian cancer (which can be associated with colon cancer)
  • Family history of gastric cancer
  • Family history of pancreatic cancer

The High-Risk GI Cancer Genetics program evaluates individuals with a strong family history of gastrointestinal cancer, especially colon cancer. Our goal is to serve not only patients, but also their families and referring physicians with up-to-date recommendations surrounding the complicated issues of clinical screening as well as genetic testing.

We encourage referrals of patients, their affected family members, and also those at-risk in their families. Recommendations will be made for clinical screening and surveillance, and when appropriate, genetic testing will be offered.

We have ongoing clinical trials in many of these areas.

Our Staff

Daniel Chung, MD, Director, GI Cancer Genetics Program
Eunice Kwak, MD, PhD 
Andrew Chan, MD, MPH

Genetic Counselors

Kristen M. Shannon, M.S.
Devanshi Patel, M.S.
Gayun Chan-Smutko, M.S.
Janette Lawrence, M.S.
Michele Gabree, M.S.